Abstract:Preterm infants frequently suffer from pulmonary complications due to a physiological and structural lung immaturity resulting in significant morbidity and mortality. Novel in vitro and in vivo models are required to study the underlying mechanisms of late lung maturation and to facilitate the development of new therapeutic strategies. Organoids recapitulate essential aspects of structural organization and possibly organ function, and can be used to model developmental and disease processes. We aimed at generating fetal lung organoids (LOs) and to functionally characterize this in vitro model in comparison to primary lung epithelial cells and lung explants ex vivo . LOs were generated with alveolar and endothelial cells from fetal rat lung tissue, using a Matrigel-gradient and air-liquid-interface culture conditions. Immunocytochemical analysis showed that the LOs consisted of polarized epithelial cell adhesion molecule (EpCAM)-positive cells with the apical membrane compartment facing the organoid lumen. Expression of the alveolar type 2 cell marker, RT2-70, and the Club cell marker, CC-10, were observed. Na + transporter and surfactant protein mRNA expression were detected in the LOs. First time patch clamp analyses demonstrated the presence of several ion channels with specific electrophysiological properties, comparable to vital lung slices. Furthermore, the responsiveness of LOs to glucocorticoids was demonstrated. Finally, maturation of LOs induced by mesenchymal stem cells confirmed the convenience of the model to test and establish novel therapeutic strategies. The results showed that fetal LOs replicate key biological lung functions essential for lung maturation and therefore constitute a suitable in vitro model system to study lung development and related diseases.

A distal lung organoid model to study interstitial lung disease, viral infection and human lung development

Design, infectability, and transcriptomic analysis of transregionally differentiated and scalable lung organoids derived from adult bronchial cells.

Generation of Complete Multi−Cell Type Lung Organoids From Human Embryonic and Patient‐Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation

Lung Organoids—The Ultimate Tool to Dissect Pulmonary Diseases?

Human Lung Organoids—A Novel Experimental and Precision Medicine Approach

Open questions in human lung organoid research

Generation of Human Embryonic Stem Cell-Derived Lung Organoids

Isolation, Culture, and Phenotypic Analysis of Murine Lung Organoids

Human lung organoid: Models for respiratory biology and diseases

Recent advances in lung organoid development and applications in disease modeling

Influence of Microenvironmental Orchestration on Multicellular Lung Alveolar Organoid Development from Human Induced Pluripotent Stem Cells

Advanced lung organoids for respiratory system and pulmonary disease modeling

Long-term expanding human airway organoids for disease modeling

Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives

Alveolar Organoids in Lung Disease Modeling

Development and Functional Characterization of Fetal Lung Organoids

Progenitor identification and SARS-CoV-2 infection in human distal lung organoids

Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease

Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease

Organoids As a Powerful Model for Respiratory Diseases

Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling